Location
Boston, MA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
23
Total value ($000)
$1,489,841
Net value change ($000)
-192,180 (-11.4%)
New positions
4
Sold out positions
2
Turnover %
22.0%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ADARX PHARMACEUTICALS INC 134,176 NEW
TARS 86,168 NEW
FREENOME INC 37,256 NEW
DYN 30,609 NEW
ALKERMES PLC 26,140 25.7%
AVIR 1,162 12.0%
Top Reduces (Value $000, Stocks/ETFs)
KAILERA THERAPEUTICS INC -239,608 -48.2%
NAMS -36,429 -28.2%
DNTH -35,334 -100.0%
OLMA -27,419 -30.9%
SLDB -27,072 -27.6%
HTFL -26,573 -10.7%
SVRA -17,601 -16.2%
KYTX -16,783 -65.3%
PHVS -15,600 -16.9%
XFOR -14,102 -37.9%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type